Publications by authors named "Christophe Merlette"

Claim this Profile
P
PRPS1 loss-of-function variants, from isolated hearing loss to severe congenital encephalopathy: New cases and literature review.
Oriane Mercati, Marie-Thérèse Abi Warde, Geneviève Lina-Granade, Marlène Rio, Solveig Heide, Christophe Merlette

Eur J Med Genet· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The contribution of Raman spectroscopy to the analytical quality control of cytotoxic drugs in a hospital environment: eliminating the exposure risks for staff members and their work environment.
Philippe Bourget, Alexandre Amin, Fabrice Vidal, Christophe Merlette, Pénélope Troude

Int J Pharm· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a CO2-releasing suppository in dyschezia: a double-blind, randomized, placebo-controlled clinical trial.
Anne Laure Tarrerias, Laurent Abramowitz, Marc M L Marty, Pierre Coulom, Ghislain Staumont, Christophe Merlette

Dig Liver Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Raman spectroscopy vs. high performance liquid chromatography for quality control of complex therapeutic objects: model of elastomeric portable pumps filled with a fluorouracil solution.
Philippe Bourget, Alexandre Amin, Fabrice Vidal, Christophe Merlette, Frédéric Lagarce

J Pharm Biomed Anal· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis.
Philippe Bourget, Alexandre Amin, Marie-Olivia Chandesris, Fabrice Vidal, Christophe Merlette

J Chromatogr B Analyt Technol Biomed Life Sci· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations].
Philippe Bourget, Ludivine Falaschi, Felipe Suarez, Valérie Galland, Dominique Blot, Christophe Merlette

Bull Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis